Durvalumab and Standard Chemotherapy Before Surgery in Treating Patients With Variant Histology Bladder Cancer

Conditions:   Bladder Adenocarcinoma;   Bladder Mixed Adenocarcinoma;   Bladder Squamous Cell Carcinoma;   Bladder Urothelial Carcinoma;   Infiltrating Bladder Urothelial Carcinoma Sarcomatoid Variant;   Infiltrating Bladder Urothelial Carcinoma With Giant Cells;   Infiltrating Bladder Urothelia l Carcinoma With Glandular Differentiation;   Infiltrating Bladder Urothelial Carcinoma With Trophoblastic Differentiation;   Infiltrating Bladder Urothelial Carcinoma, Clear Cell Variant;   Infiltrating Bladder Urothelial Carcinoma, Micropapillary Variant;   Infiltrating Bladder Urothelial Carc inoma, Nested Variant;   Infiltrating Bladder Urothelial Carcinoma, Plasmacytoid Variant Interventions:   Drug: Carboplatin;   Drug: Cisplatin;   Procedure: Cystectomy;   Drug: Doxorubicin;   Biological: Durvalumab;   Drug: Gemcitabine;   Drug: Methotrexate;   Drug: Vinblastine Sponsors:   Stanford University;   AstraZeneca Recruiting
Source: ClinicalTrials.gov - Category: Research Source Type: clinical trials